Search results for: *

Forum Tag Subject Thread Poster Comments Created with Sketch. Views Created with Sketch. Likes Created with Sketch. Date Created with Sketch.
ASX - By Stock MSB Re: MSB Trading - 2020 Thread PFB63 23K 13M 4 18/05/20
18/05/20 ASX - By Stock Comments Created with Sketch. 23K Views Created with Sketch. 13M Likes Created with Sketch. 4
ASX - By Stock MSB Re: Cell Therapy News/Articles Thread PFB63 17K 6.7M 6 18/05/20
18/05/20 ASX - By Stock Comments Created with Sketch. 17K Views Created with Sketch. 6.7M Likes Created with Sketch. 6
ASX - By Stock MSB Re: MSB Trading - 2020 Thread PFB63 23K 13M 9 17/05/20
17/05/20 ASX - By Stock Comments Created with Sketch. 23K Views Created with Sketch. 13M Likes Created with Sketch. 9
ASX - By Stock CHN Re: 20 Thread PFB63 30 703K 0 17/05/20
17/05/20 ASX - By Stock Comments Created with Sketch. 30 Views Created with Sketch. 703K Likes Created with Sketch. 0
ASX - By Stock MSB Re: Mesoblast gets one more roll of the dice Thread PFB63 79 45K 8 13/05/20
13/05/20 ASX - By Stock Comments Created with Sketch. 79 Views Created with Sketch. 45K Likes Created with Sketch. 8
ASX - By Stock MSB Re: Ann: Trading Halt Thread PFB63 933 436K 18 12/05/20
12/05/20 ASX - By Stock Comments Created with Sketch. 933 Views Created with Sketch. 436K Likes Created with Sketch. 18
ASX - By Stock CHN Re: Ann: Trading Halt Thread PFB63 195 93K 3 12/05/20
12/05/20 ASX - By Stock Comments Created with Sketch. 195 Views Created with Sketch. 93K Likes Created with Sketch. 3
ASX - By Stock MSB Re: $MESO Started Phase 2/3 Covid ARDS trial 3 days ago with 6 locations now expanded to 14! Thread PFB63 87 48K 2 11/05/20
11/05/20 ASX - By Stock Comments Created with Sketch. 87 Views Created with Sketch. 48K Likes Created with Sketch. 2
ASX - By Stock KLL Re: Whats going on here Thread PFB63 72 38K 4 08/05/20
08/05/20 ASX - By Stock Comments Created with Sketch. 72 Views Created with Sketch. 38K Likes Created with Sketch. 4
ASX - By Stock MSB Re: Cell Therapy News/Articles Thread PFB63 17K 6.7M 3 08/05/20
08/05/20 ASX - By Stock Comments Created with Sketch. 17K Views Created with Sketch. 6.7M Likes Created with Sketch. 3
ASX - By Stock MSB Re: MSB Trading - 2020 Thread PFB63 23K 13M 5 06/05/20
06/05/20 ASX - By Stock Comments Created with Sketch. 23K Views Created with Sketch. 13M Likes Created with Sketch. 5
ASX - By Stock MSB Re: MSB Trading - 2020 Thread PFB63 23K 13M 4 06/05/20
06/05/20 ASX - By Stock Comments Created with Sketch. 23K Views Created with Sketch. 13M Likes Created with Sketch. 4
ASX - By Stock MSB Re: Ann: First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS Thread PFB63 188 78K 11 06/05/20
06/05/20 ASX - By Stock Comments Created with Sketch. 188 Views Created with Sketch. 78K Likes Created with Sketch. 11
ASX - By Stock MSB Re: MSB Trading - 2020 Thread PFB63 23K 13M 17 05/05/20
05/05/20 ASX - By Stock Comments Created with Sketch. 23K Views Created with Sketch. 13M Likes Created with Sketch. 17
ASX - By Stock MSB Re: Cell Therapy News/Articles Thread PFB63 17K 6.7M 5 03/05/20
03/05/20 ASX - By Stock Comments Created with Sketch. 17K Views Created with Sketch. 6.7M Likes Created with Sketch. 5
ASX - By Stock MSB Re: Gilead vs Mesoblast Thread PFB63 274 111K 4 02/05/20
02/05/20 ASX - By Stock Comments Created with Sketch. 274 Views Created with Sketch. 111K Likes Created with Sketch. 4
ASX - By Stock MSB Re: Gilead vs Mesoblast Thread PFB63 274 111K 3 02/05/20
02/05/20 ASX - By Stock Comments Created with Sketch. 274 Views Created with Sketch. 111K Likes Created with Sketch. 3
ASX - By Stock MSB Re: Gilead vs Mesoblast Thread PFB63 274 111K 2 02/05/20
02/05/20 ASX - By Stock Comments Created with Sketch. 274 Views Created with Sketch. 111K Likes Created with Sketch. 2
ASX - By Stock MSB Re: Ann: Phase 2/3 Trial in COVID-19 ARDS Begins Enrollment Thread PFB63 296 99K 6 30/04/20
30/04/20 ASX - By Stock Comments Created with Sketch. 296 Views Created with Sketch. 99K Likes Created with Sketch. 6
ASX - By Stock MSB Re: Ann: Phase 2/3 Trial in COVID-19 ARDS Begins Enrollment Thread PFB63 296 99K 0 30/04/20
30/04/20 ASX - By Stock Comments Created with Sketch. 296 Views Created with Sketch. 99K Likes Created with Sketch. 0
ASX - By Stock MSB Re: MESO action tonight Thread PFB63 3.1K 1.4M 1 30/04/20
30/04/20 ASX - By Stock Comments Created with Sketch. 3.1K Views Created with Sketch. 1.4M Likes Created with Sketch. 1
ASX - By Stock MSB Re: MESO action tonight Thread PFB63 3.1K 1.4M 6 30/04/20
30/04/20 ASX - By Stock Comments Created with Sketch. 3.1K Views Created with Sketch. 1.4M Likes Created with Sketch. 6
ASX - By Stock MSB Re: Ann: Phase 2/3 Trial in COVID-19 ARDS Begins Enrollment Thread PFB63 296 99K 2 30/04/20
30/04/20 ASX - By Stock Comments Created with Sketch. 296 Views Created with Sketch. 99K Likes Created with Sketch. 2
ASX - By Stock MSB Re: Ann: Phase 2/3 Trial in COVID-19 ARDS Begins Enrollment Thread PFB63 296 99K 26 30/04/20
30/04/20 ASX - By Stock Comments Created with Sketch. 296 Views Created with Sketch. 99K Likes Created with Sketch. 26
ASX - By Stock MSB Re: MSB Trading - 2020 Thread PFB63 23K 13M 7 29/04/20
29/04/20 ASX - By Stock Comments Created with Sketch. 23K Views Created with Sketch. 13M Likes Created with Sketch. 7
ASX - By Stock MSB Re: Cell Therapy News/Articles Thread PFB63 17K 6.7M 2 29/04/20
29/04/20 ASX - By Stock Comments Created with Sketch. 17K Views Created with Sketch. 6.7M Likes Created with Sketch. 2
ASX - By Stock MSB Re: Cell Therapy News/Articles Thread PFB63 17K 6.7M 0 29/04/20
29/04/20 ASX - By Stock Comments Created with Sketch. 17K Views Created with Sketch. 6.7M Likes Created with Sketch. 0
ASX - By Stock MSB Re: Cell Therapy News/Articles Thread PFB63 17K 6.7M 3 29/04/20
29/04/20 ASX - By Stock Comments Created with Sketch. 17K Views Created with Sketch. 6.7M Likes Created with Sketch. 3
ASX - By Stock MSB Re: US Analyst update today Thread PFB63 7 2.7K 3 28/04/20
28/04/20 ASX - By Stock Comments Created with Sketch. 7 Views Created with Sketch. 2.7K Likes Created with Sketch. 3


arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.